68001-0534 Bortezomib

Product NDC:

68001-0534

Brand Name:

Bortezomib

Generic Name:

Bortezomib

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: BORTEZOMIB

Strength: 3.5

Unit: mg/1

Packages:

Code: 68001-0534-36

Description: 1 VIAL in 1 CARTON (68001-534-36) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Effective Date: July 31, 2022

Discontinued: April 29, 2025

SEER*Rx Category:

Chemotherapy

Major Class:

Proteasome Inhibitor

Minor Class:

26S

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox